Cargando…

Size and depth of residual tumor after neoadjuvant chemoradiotherapy in rectal cancer – implications for the development of new imaging modalities for response assessment

With the shift towards organ preserving treatment strategies in rectal cancer it has become increasingly important to accurately discriminate between a complete and good clinical response after neoadjuvant chemoradiotherapy (CRT). Standard of care imaging techniques such as CT and MRI are well equip...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Stel, Stefan D., van den Berg, Jose G., Snaebjornsson, Petur, Seignette, Iris M., Witteveen, Mark, Grotenhuis, Brechtje A., Beets, Geerard L., Post, Anouk L., Ruers, Theo J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509550/
https://www.ncbi.nlm.nih.gov/pubmed/37736547
http://dx.doi.org/10.3389/fonc.2023.1209732
_version_ 1785107756109266944
author van der Stel, Stefan D.
van den Berg, Jose G.
Snaebjornsson, Petur
Seignette, Iris M.
Witteveen, Mark
Grotenhuis, Brechtje A.
Beets, Geerard L.
Post, Anouk L.
Ruers, Theo J. M.
author_facet van der Stel, Stefan D.
van den Berg, Jose G.
Snaebjornsson, Petur
Seignette, Iris M.
Witteveen, Mark
Grotenhuis, Brechtje A.
Beets, Geerard L.
Post, Anouk L.
Ruers, Theo J. M.
author_sort van der Stel, Stefan D.
collection PubMed
description With the shift towards organ preserving treatment strategies in rectal cancer it has become increasingly important to accurately discriminate between a complete and good clinical response after neoadjuvant chemoradiotherapy (CRT). Standard of care imaging techniques such as CT and MRI are well equipped for initial staging of rectal tumors, but discrimination between a good clinical and complete response remains difficult due to their limited ability to detect small residual vital tumor fragments. To identify new promising imaging techniques that could fill this gap, it is crucial to know the size and invasion depth of residual vital tumor tissue since this determines the requirements with regard to the resolution and imaging depth of potential new optical imaging techniques. We analyzed 198 pathology slides from 30 rectal cancer patients with a Mandard tumor regression grade 2 or 3 after CRT that underwent surgery. For each patient we determined response pattern, size of the largest vital tumor fragment or bulk and the shortest distance from the vital tumor to the luminal surface. The response pattern was shrinkage in 14 patients and fragmentation in 16 patients. For both groups combined, the largest vital tumor fragment per patient was smaller than 1mm for 38% of patients, below 0.2mm for 12% of patients and for one patient as small as 0.06mm. For 29% of patients the vital tumor remnant was present within the first 0.01mm from the luminal surface and for 87% within 0.5mm. Our results explain why it is difficult to differentiate between a good clinical and complete response in rectal cancer patients using endoscopy and MRI, since in many patients submillimeter tumor fragments remain below the luminal surface. To detect residual vital tumor tissue in all patients included in this study a technique with a spatial resolution of 0.06mm and an imaging depth of 8.9mm would have been required. Optical imaging techniques offer the possibility of detecting majority of these cases due to the potential of both high-resolution imaging and enhanced contrast between tissue types. These techniques could thus serve as a complimentary tool to conventional methods for rectal cancer response assessment.
format Online
Article
Text
id pubmed-10509550
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105095502023-09-21 Size and depth of residual tumor after neoadjuvant chemoradiotherapy in rectal cancer – implications for the development of new imaging modalities for response assessment van der Stel, Stefan D. van den Berg, Jose G. Snaebjornsson, Petur Seignette, Iris M. Witteveen, Mark Grotenhuis, Brechtje A. Beets, Geerard L. Post, Anouk L. Ruers, Theo J. M. Front Oncol Oncology With the shift towards organ preserving treatment strategies in rectal cancer it has become increasingly important to accurately discriminate between a complete and good clinical response after neoadjuvant chemoradiotherapy (CRT). Standard of care imaging techniques such as CT and MRI are well equipped for initial staging of rectal tumors, but discrimination between a good clinical and complete response remains difficult due to their limited ability to detect small residual vital tumor fragments. To identify new promising imaging techniques that could fill this gap, it is crucial to know the size and invasion depth of residual vital tumor tissue since this determines the requirements with regard to the resolution and imaging depth of potential new optical imaging techniques. We analyzed 198 pathology slides from 30 rectal cancer patients with a Mandard tumor regression grade 2 or 3 after CRT that underwent surgery. For each patient we determined response pattern, size of the largest vital tumor fragment or bulk and the shortest distance from the vital tumor to the luminal surface. The response pattern was shrinkage in 14 patients and fragmentation in 16 patients. For both groups combined, the largest vital tumor fragment per patient was smaller than 1mm for 38% of patients, below 0.2mm for 12% of patients and for one patient as small as 0.06mm. For 29% of patients the vital tumor remnant was present within the first 0.01mm from the luminal surface and for 87% within 0.5mm. Our results explain why it is difficult to differentiate between a good clinical and complete response in rectal cancer patients using endoscopy and MRI, since in many patients submillimeter tumor fragments remain below the luminal surface. To detect residual vital tumor tissue in all patients included in this study a technique with a spatial resolution of 0.06mm and an imaging depth of 8.9mm would have been required. Optical imaging techniques offer the possibility of detecting majority of these cases due to the potential of both high-resolution imaging and enhanced contrast between tissue types. These techniques could thus serve as a complimentary tool to conventional methods for rectal cancer response assessment. Frontiers Media S.A. 2023-09-05 /pmc/articles/PMC10509550/ /pubmed/37736547 http://dx.doi.org/10.3389/fonc.2023.1209732 Text en Copyright © 2023 van der Stel, van den Berg, Snaebjornsson, Seignette, Witteveen, Grotenhuis, Beets, Post and Ruers https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
van der Stel, Stefan D.
van den Berg, Jose G.
Snaebjornsson, Petur
Seignette, Iris M.
Witteveen, Mark
Grotenhuis, Brechtje A.
Beets, Geerard L.
Post, Anouk L.
Ruers, Theo J. M.
Size and depth of residual tumor after neoadjuvant chemoradiotherapy in rectal cancer – implications for the development of new imaging modalities for response assessment
title Size and depth of residual tumor after neoadjuvant chemoradiotherapy in rectal cancer – implications for the development of new imaging modalities for response assessment
title_full Size and depth of residual tumor after neoadjuvant chemoradiotherapy in rectal cancer – implications for the development of new imaging modalities for response assessment
title_fullStr Size and depth of residual tumor after neoadjuvant chemoradiotherapy in rectal cancer – implications for the development of new imaging modalities for response assessment
title_full_unstemmed Size and depth of residual tumor after neoadjuvant chemoradiotherapy in rectal cancer – implications for the development of new imaging modalities for response assessment
title_short Size and depth of residual tumor after neoadjuvant chemoradiotherapy in rectal cancer – implications for the development of new imaging modalities for response assessment
title_sort size and depth of residual tumor after neoadjuvant chemoradiotherapy in rectal cancer – implications for the development of new imaging modalities for response assessment
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509550/
https://www.ncbi.nlm.nih.gov/pubmed/37736547
http://dx.doi.org/10.3389/fonc.2023.1209732
work_keys_str_mv AT vanderstelstefand sizeanddepthofresidualtumorafterneoadjuvantchemoradiotherapyinrectalcancerimplicationsforthedevelopmentofnewimagingmodalitiesforresponseassessment
AT vandenbergjoseg sizeanddepthofresidualtumorafterneoadjuvantchemoradiotherapyinrectalcancerimplicationsforthedevelopmentofnewimagingmodalitiesforresponseassessment
AT snaebjornssonpetur sizeanddepthofresidualtumorafterneoadjuvantchemoradiotherapyinrectalcancerimplicationsforthedevelopmentofnewimagingmodalitiesforresponseassessment
AT seignetteirism sizeanddepthofresidualtumorafterneoadjuvantchemoradiotherapyinrectalcancerimplicationsforthedevelopmentofnewimagingmodalitiesforresponseassessment
AT witteveenmark sizeanddepthofresidualtumorafterneoadjuvantchemoradiotherapyinrectalcancerimplicationsforthedevelopmentofnewimagingmodalitiesforresponseassessment
AT grotenhuisbrechtjea sizeanddepthofresidualtumorafterneoadjuvantchemoradiotherapyinrectalcancerimplicationsforthedevelopmentofnewimagingmodalitiesforresponseassessment
AT beetsgeerardl sizeanddepthofresidualtumorafterneoadjuvantchemoradiotherapyinrectalcancerimplicationsforthedevelopmentofnewimagingmodalitiesforresponseassessment
AT postanoukl sizeanddepthofresidualtumorafterneoadjuvantchemoradiotherapyinrectalcancerimplicationsforthedevelopmentofnewimagingmodalitiesforresponseassessment
AT ruerstheojm sizeanddepthofresidualtumorafterneoadjuvantchemoradiotherapyinrectalcancerimplicationsforthedevelopmentofnewimagingmodalitiesforresponseassessment